Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo.

Autophagy 2019 Feb 20;15(2):295-311. Epub 2018 Sep 20.

a School of Pharmaceutical Sciences, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation , Sun Yat-Sen University , Guangzhou , Guangdong , China.

Human Atg4 homologs are cysteine proteases, which play key roles in the macroautophagy/autophagy process by cleaving Atg8 homologs for conjugation to lipid membranes and for deconjugation of Atg8 homologs from membranes. Expression of ATG4B is significantly increased in colorectal cancer cells compared to normal cells, suggesting that ATG4B may be important for cancer biology. Inhibition of ATG4B may reduce the autophagy activity, thereby sensitizing cancer cells to therapeutic agents. Thus, developing specific and potent ATG4B inhibitors for research as well as for potential therapeutic uses is highly needed. In this study, we integrated screening and assays to discover a potent ATG4B inhibitor, named S130, from a noncommercial library. This chemical binds to ATG4B with strong affinity and specifically suppresses the activity of ATG4B but not other proteases. S130 did not cause the impairment of autophagosome fusion, nor did it result in the dysfunction of lysosomes. Instead, S130 might attenuate the delipidation of LC3-II on the autolysosomes to suppress the recycling of LC3-I, which normally occurs after LC3-II cleavage by ATG4B. Intriguingly, S130 induced cell death, which was accompanied with autophagy stress and could be further exacerbated by nutrient deprivation. Such cytotoxicity could be partially reversed by enhancing ATG4B activity. Finally, we found that S130 was distributed in tumor tissues in vivo and was also effective in arresting the growth of colorectal cancer cells. Thus, this study indicates that ATG4B is a potential anticancer target and S130 might be a novel small-molecule candidate for future cancer therapy.

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/15548627.2018.1
Publisher Site
http://dx.doi.org/10.1080/15548627.2018.1517073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333450PMC
February 2019
137 Reads

Publication Analysis

Top Keywords

cancer cells
16
colorectal cancer
12
atg4b
11
cell death
8
potent atg4b
8
atg8 homologs
8
cancer
6
s130
6
cells
5
assays discover
4
discover potent
4
distributed tumor
4
integrated screening
4
screening assays
4
s130 distributed
4
inhibitor named
4
noncommercial library
4
atg4b activity
4
library chemical
4
enhancing atg4b
4

References

(Supplied by CrossRef)

Similar Publications